Leadership Overview
Suvoda has 7 executives leading key functions including strategy, operations, marketing, finance, and regional management.
Driven by innovation, Suvoda transforms clinical trials with technology, solving complex patient randomization and supply chain challenges to empower focus on patient care. The company's leadership philosophy centers on delivering advanced, customizable solutions that ensure clinical trial success.
Driven by innovation, Suvoda transforms clinical trials with technology, solving complex patient randomization and supply chain challenges to empower focus on patient care. The company's leadership philosophy centers on delivering advanced, customizable solutions that ensure clinical trial success.
Leadership Roles at Suvoda
Jagath Wanninayake - Chief Executive Officer
Jagath Wanninayake, the Chief Executive Officer at Suvoda, directs the company's overarching strategy and vision. Wanninayake guides Suvoda's transformation of clinical trials through advanced technology, focusing on solving intricate patient randomization and supply chain complexities. This leadership ensures customers can prioritize patient care with confidence. The Chief Executive Officer's role involves setting the direction for product development, market expansion, and operational excellence, aligning all functions with the company's mission to support innovative study designs. By fostering a culture of innovation, Jagath Wanninayake drives the development of Suvoda's powerful reporting and advanced functionality, solidifying the company's position as a leader in the biopharmaceutical and clinical research sectors. The executive's strategic oversight extends to global operations, ensuring seamless service delivery to clients worldwide.
Brian Greenfield - Chief Financial Officer
Brian Greenfield, the Chief Financial Officer at Suvoda, manages the company's financial operations and strategic fiscal planning. Greenfield oversees all aspects of financial reporting, budgeting, and resource allocation, ensuring the company's financial health and stability. The Chief Financial Officer's role is critical in supporting Suvoda's growth initiatives and investments in technology that transforms clinical trials. By providing financial insights and controls, Brian Greenfield enables the organization to effectively manage complex patient randomization and clinical trial supply chain challenges. This leadership ensures that financial resources are aligned with the development of advanced functionality and the expansion of services to biopharmaceutical companies and clinical research organizations globally, reinforcing Suvoda's commitment to sustainable success.
John Samar - Chief Financial Officer & Founder
John Samar, the Chief Financial Officer & Founder at Suvoda, provides foundational financial leadership and strategic direction. Samar's dual role encompasses both the fiscal management of the company and the entrepreneurial vision that established Suvoda's innovative approach to clinical trials. The Chief Financial Officer & Founder's responsibilities include guiding financial strategy, ensuring robust fiscal controls, and contributing to the company's long-term growth trajectory. This leadership ensures that Suvoda's technology, including its Interactive Response Technology (IRT) system, is supported by sound financial planning, enabling the resolution of complex patient randomization and supply chain challenges. John Samar's influence extends to fostering the company culture and driving the development of advanced features for biopharmaceutical clients worldwide.
Jp Samar - Chief Financial Officer & Founder
Jp Samar, the Chief Financial Officer & Founder at Suvoda, contributes essential financial oversight and strategic founding principles. Samar's role integrates financial management with the core vision that drives Suvoda's innovation in clinical trial technology. The Chief Financial Officer & Founder's responsibilities focus on maintaining financial discipline, supporting operational scaling, and contributing to the company's strategic objectives. This leadership ensures that Suvoda's commitment to solving complex patient randomization and supply chain challenges is underpinned by strong financial governance. Jp Samar's involvement reinforces the company's dedication to providing advanced functionality and exceptional service to biopharmaceutical companies and clinical research organizations, driving forward the mission of transforming clinical trials.
Robert Hummel - Chief Operating Officer
Robert Hummel, the Chief Operating Officer at Suvoda, oversees the company's global operational execution and service delivery. Hummel ensures that Suvoda's Interactive Response Technology (IRT) system effectively addresses complex patient randomization and clinical trial supply chain challenges across all client engagements. The Chief Operating Officer's responsibilities include optimizing internal processes, managing cross-functional teams, and maintaining the high standards of customer and advisory services offered to biopharmaceutical companies and clinical research organizations. By driving operational efficiency, Robert Hummel supports the company's ability to offer configurable and customizable features, powerful reporting, and advanced functionality. This leadership ensures Suvoda's infrastructure scales to support complex and innovative study designs, reinforcing the company's commitment to client success and operational integrity worldwide.
Yuko Fukasaku - President, Suvoda (Japan)
Yuko Fukasaku, the President, Suvoda (Japan) at Suvoda, leads the company's strategic initiatives and operational management within the Japanese market. Fukasaku is responsible for expanding Suvoda's presence and impact in Japan, ensuring the effective deployment of its Interactive Response Technology (IRT) system to address local clinical trial needs. The President, Suvoda (Japan)'s role involves fostering strong relationships with biopharmaceutical companies and clinical research organizations in the region, tailoring Suvoda's solutions to meet specific market demands. By driving regional growth, Yuko Fukasaku supports the delivery of configurable and customizable features, powerful reporting, and advanced functionality. This leadership ensures Suvoda's commitment to transforming clinical trials extends globally, reinforcing the company's mission to solve complex patient randomization and supply chain challenges.
Elena Filimonova - Chief Marketing Officer
Elena Filimonova, the Chief Marketing Officer at Suvoda, directs the company's global marketing strategy and brand positioning. Filimonova is responsible for communicating Suvoda's value proposition in transforming clinical trials through technology, highlighting the IRT system's capabilities in solving complex patient randomization and supply chain issues. The Chief Marketing Officer's role involves developing and executing integrated marketing campaigns that reach biopharmaceutical companies and clinical research organizations of all sizes, emphasizing Suvoda's commitment to customer success and innovation. By driving market awareness, Elena Filimonova supports the adoption of Suvoda's configurable features, powerful reporting, and advanced functionality. This leadership ensures the company's message resonates with the industry, underscoring Suvoda's impact on enabling complex and innovative study designs and reinforcing its global presence.
Explore Leadership Teams in Healthcare Software
Verily Life Sciences LLC is a U.S.-based healthcare technology company and subsidiary of Alphabet Inc., focused on improving health outcomes through data-driven research and digital health solutions. Founded in 2015, Verily develops software platforms, analytics tools, and clinical research systems designed to integrate and analyze large-scale biomedical and health data.
Company Leadership
DR
Greenway Health, founded in 1977 and headquartered in Tampa, Florida, is a vendor of health information technology including integrated electronic health records, practice management, and revenue cycle management solutions.
Company Leadership AG
MR
KM
GB
Included Health is a new kind of healthcare company. We combine people and technology to guide and deliver care differently. Working with employers and health plans nationwide, we provide millions of people with a healthcare experience that is more personalized, accessible, equitable, affordable, and cohesive. With us, its all included; care and support online, around the corner, and in the home for everyday and urgent needs including primary, specialty, and behavioral healthcare. Our model is designed to treat people better.
Company Leadership AY
Noom operates a digital health platform designed to facilitate meaningful behavior change through structured wellness courses. The company develops evidence-based programs that address chronic health conditions and lifestyle management, combining behavioral psychology with accessible digital delivery to reach individuals seeking sustainable health improvements. The platform delivers comprehensive courses that guide users through personalized health journeys, integrating coaching, tracking tools, and community support mechanisms. Noom's approach emphasizes understanding the psychological drivers behind health behaviors, translating clinical research into practical, actionable guidance that users can implement in their daily lives. The courses address various health concerns and wellness objectives, with content developed to meet users at different stages of their health transformation. Noom serves a diverse user base seeking preventive care and chronic disease management solutions outside traditional healthcare settings. The platform's model enables scalable delivery of health interventions, making professional-grade behavioral support accessible to individuals who might otherwise lack access to specialized coaching. By combining technology infrastructure with behavioral science principles, Noom bridges gaps in conventional health delivery systems.
Company Leadership JC
SB
Frequently Asked Questions Regarding Suvoda Top Executives and Leadership Team
